In 2010, Pfizer Inc. launched a global fleet safety program, which has been implemented in three phases. The latest issue of the Transportation Practice Specialty’s online technical publication, TransActions, includes a case study of how this program was developed and launched and also identifies how Pfizer:
• worked to develop and communicate the business case and benefits of improved fleet safety
• benchmarked and analyzed opportunities to improve driver safety performance
• evaluates the program’s success in terms of process, compliance, safety performance, costs, company reputation and corporate social responsibility
While rollout of these three phases will continue this year, many of Pfizer’s markets have already seen reduced collision rates. Click here to read more about the success of Pfizer’s driver safety program.
A Blog From the American Society of Safety Engineers
